Evidence map›Paper›PMID 35712862›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2022

Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.

Sarah J Nyante, Linn Abraham, Erin J Aiello Bowles, Christoph I Lee, Karla Kerlikowske, Diana L Miglioretti, Brian L Sprague, Louise M Henderson, Breast Cancer Surveillance Consortium

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Racial and Ethnic Variation in Diagnostic Mammography Performance among Women Reporting a Breast Lump.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Sarah J NyanteDepartment of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0002-1770-5993
Linn AbrahamKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington.ORCID 0000-0002-0840-1947
Erin J Aiello BowlesKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington.ORCID 0000-0001-6287-7391
Christoph I LeeDepartment of Radiology, University of Washington School of Medicine, Seattle, Washington.ORCID 0000-0002-8185-7721
Karla KerlikowskeDepartment of Medicine, University of California, San Francisco, San Francisco, California.ORCID 0000-0001-8793-8779
Diana L MigliorettiKaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington.ORCID 0000-0002-5547-1833
Brian L SpragueDepartment of Surgery and University of Vermont Cancer Center, University of Vermont, Burlington, Vermont.
Louise M HendersonDepartment of Radiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.ORCID 0000-0001-8356-9267
Breast Cancer Surveillance Consortium
Kaiser Permanente Washington Health Research Institute · USUniversity of North Carolina at Chapel Hill · USSan Francisco VA Medical Center · USUniversity of Vermont · USUniversity of Washington · US

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Diana L Miglioretti · 2011 to 2026
$52.9M
Vermont Screening Process Documentation UnitU54CA163303 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L · 2011 to 2017
$6.4M
Racial and Socioeconomic Disparities in Breast Cancer Diagnostic Work Up and OutcomesR01CA266377 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI LEE, CHRISTOPH I · 2021 to 2025
$3.1M
Comparative effectiveness of breast imaging modalities: a natural experimentR01HS018366 · AHRQ · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RAUSCHER, GARTH H · 2010 to 2014
$1.8M
Group Health Cancer Research Program Research Specialist AwardR50CA211115 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI BOWLES, ERIN JANELLE AIELLO · 2017 to 2021
$919k
AHRQ HHS R01 HS018366NCI NIH HHS P01 CA154292NCI NIH HHS R01 CA266377NCI NIH HHS R50 CA211115NCI NIH HHS U54 CA163303
6 · The paper itself

Abstract

backgroundWe evaluated differences in diagnostic mammography performance based on women's race/ethnicity.

methodsThis cohort study included 267,868 diagnostic mammograms performed to evaluate screening mammogram findings at 98 facilities in the Breast Cancer Surveillance Consortium between 2005 and 2017. Mammogram assessments were recorded prospectively and breast cancers occurring within one year were ascertained. Performance statistics were calculated with 95% confidence intervals (CI) for each racial/ethnic group. Multivariable regression was used to control for personal characteristics and imaging facility.

resultsAmong non-Hispanic White (70%), non-Hispanic Black (13%), Asian/Pacific Islander (10%), and Hispanic (7%) women, the invasive cancer detection rate (iCDR, per 1,000 mammograms) and positive predictive value (PPV2) were highest among non-Hispanic White women (iCDR, 35.8; 95% CI, 35.0-36.7; PPV2, 27.8; 95% CI, 27.3-28.3) and lowest among Hispanic women (iCDR, 22.3; 95% CI, 20.2-24.6; PPV2, 19.4; 95% CI, 18.0-20.9). Short interval follow-up recommendations were most common among non-Hispanic Black women [(31.0%; 95% CI, 30.6%-31.5%) vs. other groups, range, 16.6%-23.6%]. False-positive biopsy recommendations were most common among Asian/Pacific Islander women [per 1,000 mammograms: 169.2; 95% CI, 164.8-173.7) vs. other groups, range, 126.5-136.1]. Some differences were explained by adjusting for receipt of diagnostic ultrasound or MRI for iCDR and imaging facility for short-interval follow-up. Other differences changed little after adjustment.

conclusionsDiagnostic mammography performance varied across racial/ethnic groups. Addressing characteristics related to imaging facility and access, rather than personal characteristics, may help reduce some of these disparities. IMPACT: Diagnostic mammography performance studies should include racially and ethnically diverse populations to provide an accurate view of the population-level effects.

Indexed as

Breast NeoplasmsEthnicityCohort StudiesEarly Detection of CancerFemaleHumansMammographyMass Screening

Identifiers

PMID35712862
PMCPMC9272467
OpenAlexW4283073740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.